Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress (news with additional features) | Placera

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress (news with additional features) (EQS Newswire) 2021-09-21 07:00 DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Half Year Results 21.09.2021 / 07:00 The issuer is solely responsible for the content of this announcement. Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress Strategic regional licensing partnership with Simcere Pharmaceutical Group to treat AD in Greater China US Phase 2 VIVA-MIND study for varoglutamstat in AD initiated as planned Conference call and webcast scheduled for September 21, 2021 at 3:00 pm CEST / 9:00 am EDT…